<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Schizophr Bull</journal-id>
<journal-id journal-id-type="iso-abbrev">Schizophr Bull</journal-id>
<journal-id journal-id-type="publisher-id">schbul</journal-id>
<journal-title-group>
<journal-title>Schizophrenia Bulletin</journal-title>
</journal-title-group>
<issn pub-type="ppub">0586-7614</issn>
<issn pub-type="epub">1745-1701</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>US</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29040797</article-id>
<article-id pub-id-type="pmc">6007411</article-id>
<article-id pub-id-type="doi">10.1093/schbul/sbx113</article-id>
<article-id pub-id-type="publisher-id">sbx113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Regular Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Niarchou</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="aff" rid="AF0003">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Calkins</surname>
<given-names>Monica E</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Tyler M</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Sunny X</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McDonald-McGinn</surname>
<given-names>Donna M</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zackai</surname>
<given-names>Elaine H</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Emanuel</surname>
<given-names>Beverly S</given-names>
</name>
<xref ref-type="aff" rid="AF0004">4</xref>
<xref ref-type="aff" rid="AF0005">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gur</surname>
<given-names>Ruben C</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gur</surname>
<given-names>Raquel E</given-names>
</name>
<xref ref-type="corresp" rid="c1"></xref>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0006">6</xref>
<!--<email>Raquel@upenn.edu</email>-->
</contrib>
</contrib-group>
<aff id="AF0001"><label>1</label>Department of Psychiatry, Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff>
<aff id="AF0002"><label>2</label>MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK</aff>
<aff id="AF0003"><label>3</label>Institute of Molecular Bioscience, University of Queensland, Brisbane, Australia</aff>
<aff id="AF0004"><label>4</label>Division of Human Genetics, The Children’s Hospital of Philadelphia, Philadelphia, PA</aff>
<aff id="AF0005"><label>5</label>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA</aff>
<aff id="AF0006"><label>6</label>Department of Child and Adolescent Psychiatry, The Children’s Hospital of Philadelphia, Philadelphia, PA</aff>
<author-notes>
<corresp id="c1">To whom correspondence should be addressed; Department of Psychiatry, Neuropsychiatry Section, Perelman School of Medicine, University of Pennsylvania, 10th Floor Gates Building, 3400 Spruce Street, Philadelphia, PA 19104, US; tel: +12156622915, fax: +12156627903, e-mail: <email>Raquel@upenn.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2017-10-10" pub-type="epub">
<day>10</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>44</volume>
<issue>4</issue>
<fpage>824</fpage>
<lpage>833</lpage>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">https://academic.oup.com/journals/pages/about_us/legal/notices</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="sbx113.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<sec id="s01">
<title>Objective</title>
<p>22q11.2 Deletion Syndrome (22q11.2DS) is associated with increased risk for schizophrenia in adulthood while Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent diagnosis in childhood. Inattention symptoms are pronounced in 22q11.2DS and given that attentional impairment is a core feature of schizophrenia, inattention symptoms may reflect underlying ADHD, psychosis, or both. We investigate whether inattention is associated with psychosis in 22q11.2DS and in other groups at risk for psychosis but without the deletion (ND) (idiopathic clinical risk and first degree family members of individuals with schizophrenia).</p>
</sec>
<sec id="s02">
<title>Methods</title>
<p>One hundred thirty-seven individuals with 22q11.2DS (mean age: 14.0), 84 ND individuals with subthreshold psychosis (mean age: 16.9) and 31 ND individuals with family history of psychosis (mean age: 17.0) were included in the study. Psychopathology was assessed using research diagnostic assessments.</p>
</sec>
<sec id="s03">
<title>Results</title>
<p>ADHD total symptoms were associated with overall levels of subthreshold psychosis symptoms in 22q11.2DS (β = .8, <italic>P</italic> = .04). Inattention symptoms were specifically associated with positive (β = .5, <italic>P</italic> = .004), negative (β = .5, <italic>P</italic> = .03), and disorganized (β = .5, <italic>P</italic> &lt; .001) symptoms, while hyperactivity-impulsivity symptoms were associated with disorganized symptoms (β = .5, <italic>P</italic> = .01). The prevalence of ADHD inattention symptoms was higher in 22q11.2DS with subthreshold psychosis compared to ND individuals with subthreshold psychosis (<italic>P</italic> &lt; .001), even when adjusting for cognitive impairment and overall psychopathology. The pattern was similar when comparing individuals with 22q11.2DS and ND individuals with family history of psychosis.</p>
</sec>
<sec id="s04">
<title>Conclusions</title>
<p>This is the first study to examine the associations between ADHD symptoms and psychosis in 22q11.2DS. Our findings support a potentially important role of ADHD inattention symptoms in psychosis in 22q11.2DS.</p>
</sec>
</abstract>
<kwd-group>
<kwd>schizophrenia</kwd>
<kwd>hyperactivity</kwd>
<kwd>impulsivity</kwd>
<kwd>inattention</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Mental Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000025</named-content>
</funding-source>
<award-id>MH087626</award-id>
<award-id>MH087636</award-id>
<award-id>MH101719</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>